CONCENTRIX CORP's ticker is CNXC and the CUSIP is 20602D101. A total of 296 filers reported holding CONCENTRIX CORP in Q1 2024. The put-call ratio across all filers is 1.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $6,978,667 | +29.0% | 110,282 | +35.0% | 0.00% | 0.0% |
| Q1 2024 | $5,408,008 | +6.6% | 81,667 | +58.1% | 0.00% | 0.0% |
| Q4 2023 | $5,073,175 | +603.3% | 51,656 | +473.6% | 0.00% | – |
| Q3 2023 | $721,368 | +52.2% | 9,005 | +53.4% | 0.00% | – |
| Q2 2023 | $473,999 | -41.2% | 5,870 | -11.4% | 0.00% | – |
| Q1 2023 | $805,631 | -13.0% | 6,628 | -4.7% | 0.00% | – |
| Q4 2022 | $926,424 | +26.6% | 6,957 | +6.0% | 0.00% | – |
| Q3 2022 | $732,000 | -39.5% | 6,561 | -26.4% | 0.00% | -100.0% |
| Q2 2022 | $1,209,000 | -33.2% | 8,914 | -17.9% | 0.00% | 0.0% |
| Q1 2022 | $1,809,000 | +2.2% | 10,864 | +9.6% | 0.00% | 0.0% |
| Q4 2021 | $1,770,000 | +50.5% | 9,911 | +49.2% | 0.00% | 0.0% |
| Q3 2021 | $1,176,000 | +4.3% | 6,644 | -5.3% | 0.00% | 0.0% |
| Q2 2021 | $1,128,000 | +4.1% | 7,013 | -3.2% | 0.00% | 0.0% |
| Q1 2021 | $1,084,000 | +45.1% | 7,243 | -4.3% | 0.00% | 0.0% |
| Q4 2020 | $747,000 | – | 7,572 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Groupe Bruxelles Lambert | 8,773,667 | $555,197,648 | 100.00% |
| Impactive Capital LP | 3,846,370 | $243,398,294 | 9.46% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 623,542 | $39,457,738 | 1.80% |
| LYRICAL ASSET MANAGEMENT LP | 1,271,250 | $80,444,700 | 1.29% |
| Copeland Capital Management, LLC | 985,722 | $62,376,533 | 1.17% |
| Nierenberg Investment Management Company, Inc. | 27,910 | $1,766,145 | 0.99% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 564,732 | $35,736,207 | 0.97% |
| VALLEY WEALTH MANAGERS, INC. | 168,482 | $10,661,541 | 0.85% |
| Bragg Financial Advisors, Inc | 202,698 | $12,826,730 | 0.57% |
| CLARK ESTATES INC/NY | 44,250 | $2,800,140 | 0.53% |